2024-11-17 22:39:07
Everest Medicines Announces New Strategic Plans, Reinforcing Transformation into a Fully Integrated Biopharmaceutical Company
Corporate/ 2023-07-24
Everest Medicines Announces New Strategi...

--Focus on renal disease and mRNA platform portfolios-- --Build out commercialization capabilities in preparation for the potential approval...

ProfoundBio Announces Initiation of First-in-Human Trial for PRO1184, a Folate Receptor Alpha-Directed ADC with a Topoisomerase 1 Inhibitor Payload, and Receives FDA "Study May Proceed" Letter for PRO1160, a CD70-Directed ADC
Health/ 2023-07-22
ProfoundBio Announces Initiation of Firs...

PRO1184 first-in human study initiated and first patients dosed PRO1160 first-in-human study cleared for initiation in the US

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release